Kura Oncology (KURA)
NASDAQ:KURA
Holding KURA?
Track your performance easily

Kura Oncology (KURA) Financial Statements

491 Followers

Kura Oncology Financial Overview

Kura Oncology's market cap is currently ―. The company's EPS TTM is $-2.356; its P/E ratio is -7.50; Kura Oncology is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -54.40M$ -50.43M$ -49.13M-$ -38.20M
EBITDA$ -54.06M$ -46.83M$ -48.89M-$ -37.98M
Net Income Common Stockholders$ -54.40M$ -50.84M$ -49.52M$ -42.79M$ -38.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 455.30M$ 491.52M$ 527.12M$ 423.96M$ 452.59M
Total Assets$ 478.84M$ 515.12M$ 553.91M$ 448.94M$ 473.77M
Total Debt$ 16.63M$ 16.73M$ 16.97M$ 17.20M$ 17.42M
Net Debt$ -438.67M$ -474.79M$ -510.15M$ -406.76M$ -435.17M
Total Liabilities$ 55.07M$ 49.05M$ 48.82M$ 51.66M$ 43.83M
Stockholders Equity$ 423.77M$ 466.07M$ 505.08M$ 397.27M$ 429.94M
Cash Flow-
Free Cash Flow$ -43.44M$ -42.55M$ -48.93M-$ -29.05M
Operating Cash Flow$ -43.44M$ -42.53M$ -48.84M$ -34.31M$ -29.03M
Investing Cash Flow$ 45.53M$ 43.17M$ -95.34M$ 42.20M$ 8.56M
Financing Cash Flow$ 2.20M$ 3.04M$ 148.37M$ 691.00K$ 84.00K
Currency in USD

Kura Oncology Earnings and Revenue History

Kura Oncology Debt to Assets

Kura Oncology Cash Flow

Kura Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis